GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » Ending Cash Position

Bionomics (Bionomics) Ending Cash Position : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bionomics Ending Cash Position?

Bionomics's Ending Cash Position for the quarter that ended in Dec. 2023 was $0.00 Mil.

Bionomics's quarterly Ending Cash Position declined from Mar. 2023 ($14.99 Mil) to Jun. 2023 ($12.25 Mil) and declined from Jun. 2023 ($12.25 Mil) to Dec. 2023 ($0.00 Mil).

Bionomics's annual Ending Cash Position increased from Jun. 2021 ($21.79 Mil) to Jun. 2022 ($23.59 Mil) but then declined from Jun. 2022 ($23.59 Mil) to Jun. 2023 ($12.25 Mil).

Bionomics Ending Cash Position Historical Data

The historical data trend for Bionomics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics Ending Cash Position Chart

Bionomics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.71 3.16 21.79 23.59 12.25

Bionomics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.97 20.71 14.99 12.25 -

Bionomics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bionomics's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=22.525+-10.277
=12.25

Bionomics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Bionomics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bionomics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionomics (Bionomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » Ending Cash Position
Comparable Companies
XTER:T5O XTER:MDG1 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX OCSE:GMAB ALNY BGNE BMRN RPRX SRPT SHSE:603392 SZSE:300122
Traded in Other Exchanges
B1N0:Germany
Address
200 Greenhill Road, Eastwood, SA, AUS, 5063
Website
https://www.bionomics.com.au
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.